Roy L. Silverstein
Impact in
- Immunology top 0.1%
- Atherosclerosis and Cardiovascular Diseases
- Immune cells in cancer
- Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research
Papers in
-
- Peroxisome Proliferator-Activated Receptors 46
- Angiogenesis and VEGF in Cancer 33
- Immunology 58
- Atherosclerosis and Cardiovascular Diseases 22
- Co-authors
- Maria Febbraio (58 shared papers)David P. Hajjar (11 shared papers)Ralph L. Nachman (15 shared papers)S. Frieda A. Pearce (9 shared papers)Stanley L. Hazen (11 shared papers)Eugene A. Podrez (8 shared papers)Henry F. Hoff (5 shared papers)Noël Bouck (4 shared papers)
- Journals
- Journal of Clinical Investigation (21 papers)Journal of Biological Chemistry (20 papers)Arteriosclerosis Thrombosis and Vascular Biology (16 papers)Blood (15 papers)The Journal of Experimental Medicine (8 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Roy L. Silverstein
209 papers receiving 24.0k citations
Roy L. Silverstein's Hit Papers
Peers
Comparison fields: 5 of 148
- Immunology 7.1k
- Immunology and Allergy 1.4k
- Cancer Research 3.3k
- Hematology 2.3k
- Molecular Biology 10.9k
Countries citing papers authored by Roy L. Silverstein
This map shows the geographic impact of Roy L. Silverstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy L. Silverstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy L. Silverstein more than expected).
Fields of papers citing papers by Roy L. Silverstein
This network shows the impact of papers produced by Roy L. Silverstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy L. Silverstein. The network helps show where Roy L. Silverstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy L. Silverstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk Hit paper breakdown → | 2016 | 1455 |
| 2 | Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes Hit paper breakdown → | 1998 | 1015 |
| 3 | CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism Hit paper breakdown → | 2001 | 927 |
| 4 | CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior Hit paper breakdown → | 2009 | 919 |
| 5 | Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Hit paper breakdown → | 2000 | 834 |
| 6 | Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages Hit paper breakdown → | 2002 | 827 |
| 7 | Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice Hit paper breakdown → | 2000 | 822 |
| 8 | A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism Hit paper breakdown → | 1999 | 651 |
| 9 | Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice Hit paper breakdown → | 2000 | 558 |
| 10 | CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells Hit paper breakdown → | 1997 | 551 |
| 11 | Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis Hit paper breakdown → | 2007 | 509 |
| 12 | CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors Hit paper breakdown → | 2020 | 507 |
| 13 | 1987 | 441 | |
| 14 | 2006 | 424 | |
| 15 | 2007 | 400 | |
| 16 | 2000 | 358 | |
| 17 | 2006 | 341 | |
| 18 | 1995 | 331 | |
| 19 | 2004 | 318 | |
| 20 | 1995 | 318 |
About Roy L. Silverstein
Roy L. Silverstein is a scholar working on Molecular Biology, Immunology, Hematology, Cancer Research and Epidemiology, having authored 211 papers that have together received 24.4k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (46 papers), Angiogenesis and VEGF in Cancer (33 papers), Platelet Disorders and Treatments (32 papers), Protease and Inhibitor Mechanisms (27 papers), Cell Adhesion Molecules Research (25 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers), Atherosclerosis and Cardiovascular Diseases (22 papers) and Cancer, Lipids, and Metabolism (20 papers). The work is most often cited by research in Immunology (7.1k citations), Immunology and Allergy (1.4k citations), Cancer Research (3.3k citations), Hematology (2.3k citations) and Molecular Biology (10.9k citations). Roy L. Silverstein has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Maria Febbraio, David P. Hajjar, Ralph L. Nachman, S. Frieda A. Pearce, Stanley L. Hazen, Eugene A. Podrez, Henry F. Hoff, Noël Bouck, Nada A. Abumrad and Kavita Sharma. Their work appears in journals such as Journal of Clinical Investigation, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology, Blood and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.